
Sign up to save your podcasts
Or


DOJ’s antitrust case v. Google, new bank-capital and internet-ad rules and a 3M earplug trial appeal are key 2H catalysts to watch. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation analyst Elliott Stein, gathered the team to discuss these and other catalysts. In tech, the Microsoft-Activision M&A will probably close, despite a possible pending FTC appeal, and SCOTUS likely takes a case that shapes internet regulation. In financials, UBS may be fined over RMBS and Credit Suisse’s Archegos failings. In crypto, Coinbase’s defense will be helped by the SEC v. Ripple ruling, and we expect a decision in Grayscale v. SEC.
In health care, DOJ v. Teva goes to trial, as does Exelixis v. MSN. CMS releases Part D drugs subject to negotiation and a drug-pricing demo is possible.
See omnystudio.com/listener for privacy information.
By Bloomberg4
88 ratings
DOJ’s antitrust case v. Google, new bank-capital and internet-ad rules and a 3M earplug trial appeal are key 2H catalysts to watch. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation analyst Elliott Stein, gathered the team to discuss these and other catalysts. In tech, the Microsoft-Activision M&A will probably close, despite a possible pending FTC appeal, and SCOTUS likely takes a case that shapes internet regulation. In financials, UBS may be fined over RMBS and Credit Suisse’s Archegos failings. In crypto, Coinbase’s defense will be helped by the SEC v. Ripple ruling, and we expect a decision in Grayscale v. SEC.
In health care, DOJ v. Teva goes to trial, as does Exelixis v. MSN. CMS releases Part D drugs subject to negotiation and a drug-pricing demo is possible.
See omnystudio.com/listener for privacy information.

38,856 Listeners

1,983 Listeners

6,086 Listeners

31 Listeners